• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

干细胞疗法:是革命性的治愈方法还是潘多拉魔盒。

Stem cell therapy: a revolutionary cure or a pandora's box.

作者信息

Marei Hany E

机构信息

Department of Cytology and Histology, Faculty of Veterinary Medicine, Mansoura University, Mansoura, 35116, Egypt.

出版信息

Stem Cell Res Ther. 2025 May 22;16(1):255. doi: 10.1186/s13287-025-04334-1.

DOI:10.1186/s13287-025-04334-1
PMID:40405306
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12096755/
Abstract

This review article examines how stem cell therapies can cure various diseases and injuries while also discussing the difficulties and moral conundrums that come with their application. The article focuses on the revolutionary developments in stem cell research, especially the introduction of gene editing tools like CRISPR-Cas9, which can potentially improve the safety and effectiveness of stem cell-based treatments. To guarantee the responsible use of stem cells in clinical applications, it is also argued that standardizing clinical procedures and fortifying ethical and regulatory frameworks are essential first steps. The assessment also highlights the substantial obstacles that still need to be addressed, such as the moral dilemmas raised by the use of embryonic stem cells, the dangers of unlicensed stem cell clinics, and the difficulties in obtaining and paying for care for patients. The study emphasizes how critical it is to address these problems to stop exploitation, guarantee patient safety, and increase the accessibility of stem cell therapy. The review also addresses the significance of thorough clinical trials, public education, and policy development to guarantee that stem cell research may fulfill its full potential. The review concludes by describing stem cell research as a promising but complicated topic that necessitates a thorough evaluation of both the hazards and the benefits. To overcome the ethical, legal, and accessibility obstacles and eventually guarantee that stem cell treatments may be safely and fairly included in conventional healthcare, it urges cooperation between the scientific community, legislators, and the general public.

摘要

这篇综述文章探讨了干细胞疗法如何治愈各种疾病和损伤,同时也讨论了其应用过程中出现的困难和道德难题。文章重点关注干细胞研究的革命性进展,尤其是像CRISPR-Cas9这样的基因编辑工具的引入,这有可能提高基于干细胞治疗的安全性和有效性。文章还指出,规范临床程序以及加强伦理和监管框架是确保干细胞在临床应用中得到合理使用的关键第一步。评估还强调了仍需解决的重大障碍,比如使用胚胎干细胞引发的道德困境、无证干细胞诊所的风险,以及患者获得治疗和支付治疗费用的困难。该研究强调了解决这些问题对于防止滥用、确保患者安全以及提高干细胞治疗可及性的至关重要性。综述还阐述了全面的临床试验、公众教育和政策制定对于确保干细胞研究充分发挥其潜力的重要意义。综述最后将干细胞研究描述为一个充满希望但又复杂的课题,需要对风险和益处进行全面评估。它敦促科学界、立法者和公众之间开展合作,以克服伦理、法律和可及性障碍,并最终确保干细胞治疗能够安全、公平地纳入传统医疗保健体系。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae36/12096755/54a8bf52968f/13287_2025_4334_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae36/12096755/59b6d851051d/13287_2025_4334_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae36/12096755/32778e7da3f2/13287_2025_4334_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae36/12096755/60e939f985a0/13287_2025_4334_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae36/12096755/89ade2c15377/13287_2025_4334_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae36/12096755/4e8717fb6131/13287_2025_4334_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae36/12096755/79165b6aa664/13287_2025_4334_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae36/12096755/54a8bf52968f/13287_2025_4334_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae36/12096755/59b6d851051d/13287_2025_4334_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae36/12096755/32778e7da3f2/13287_2025_4334_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae36/12096755/60e939f985a0/13287_2025_4334_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae36/12096755/89ade2c15377/13287_2025_4334_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae36/12096755/4e8717fb6131/13287_2025_4334_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae36/12096755/79165b6aa664/13287_2025_4334_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae36/12096755/54a8bf52968f/13287_2025_4334_Fig7_HTML.jpg

相似文献

1
Stem cell therapy: a revolutionary cure or a pandora's box.干细胞疗法:是革命性的治愈方法还是潘多拉魔盒。
Stem Cell Res Ther. 2025 May 22;16(1):255. doi: 10.1186/s13287-025-04334-1.
2
Stem cell therapies for neurological disorders: current progress, challenges, and future perspectives.神经障碍的干细胞疗法:当前进展、挑战与未来展望。
Eur J Med Res. 2024 Jul 25;29(1):386. doi: 10.1186/s40001-024-01987-1.
3
Ethical issues in stem cell research and therapy.干细胞研究与治疗中的伦理问题。
Stem Cell Res Ther. 2014 Jul 7;5(4):85. doi: 10.1186/scrt474.
4
Comparative analysis of regulations and studies on stem cell therapies: focusing on induced pluripotent stem cell (iPSC)-based treatments.比较分析干细胞疗法的法规和研究:重点关注基于诱导多能干细胞(iPSC)的治疗方法。
Stem Cell Res Ther. 2024 Nov 21;15(1):447. doi: 10.1186/s13287-024-04065-9.
5
Advancing Spinal Cord Injury Treatment through Stem Cell Therapy: A Comprehensive Review of Cell Types, Challenges, and Emerging Technologies in Regenerative Medicine.通过干细胞疗法推进脊髓损伤治疗:再生医学中细胞类型、挑战及新兴技术的全面综述
Int J Mol Sci. 2023 Sep 20;24(18):14349. doi: 10.3390/ijms241814349.
6
Stem Cell-Based Disease Modeling and Cell Therapy.基于干细胞的疾病建模和细胞治疗。
Cells. 2020 Sep 29;9(10):2193. doi: 10.3390/cells9102193.
7
Assessing the Potential Benefits of Stem Cell Therapy in Cardiac Regeneration for Patients With Ischemic Heart Disease.评估干细胞疗法对缺血性心脏病患者心脏再生的潜在益处。
Cureus. 2025 Jan 1;17(1):e76770. doi: 10.7759/cureus.76770. eCollection 2025 Jan.
8
The limited application of stem cells in medicine: a review.干细胞在医学中的应用有限:综述。
Stem Cell Res Ther. 2018 Jan 2;9(1):1. doi: 10.1186/s13287-017-0735-7.
9
Can Stem Cell Therapy Revolutionize Ocular Disease Treatment? A Critical Review of Preclinical and Clinical Advances.干细胞疗法能否彻底改变眼部疾病的治疗?对临床前和临床进展的批判性综述。
Stem Cell Rev Rep. 2025 Apr 23. doi: 10.1007/s12015-025-10884-x.
10
Replacing what's lost: a new era of stem cell therapy for Parkinson's disease.替代所失之物:帕金森病干细胞治疗的新时代。
Transl Neurodegener. 2020 Jan 7;9:2. doi: 10.1186/s40035-019-0180-x. eCollection 2020.

引用本文的文献

1
Stem cell therapy offers new hope for the treatment of Alzheimer's disease.干细胞疗法为阿尔茨海默病的治疗带来了新希望。
Front Cell Dev Biol. 2025 Aug 14;13:1650885. doi: 10.3389/fcell.2025.1650885. eCollection 2025.
2
From Adipose to Action: Reprogramming Stem Cells for Functional Neural Progenitors for Neural Regenerative Therapy.从脂肪到行动:重编程干细胞生成功能性神经祖细胞用于神经再生治疗
Int J Mol Sci. 2025 Jul 9;26(14):6599. doi: 10.3390/ijms26146599.
3
Craniomaxillofacial-Derived MSCs in Congenital Defect Reconstruction.

本文引用的文献

1
Mid- to long-term efficacy and safety of stem cell therapy for acute myocardial infarction: a systematic review and meta-analysis.干细胞治疗急性心肌梗死的中远期疗效及安全性的系统评价和荟萃分析。
Stem Cell Res Ther. 2024 Sep 11;15(1):290. doi: 10.1186/s13287-024-03891-1.
2
Cause and consequence of heterogeneity in human mesenchymal stem cells: Challenges in clinical application.人类间充质干细胞异质性的原因和后果:临床应用中的挑战。
Pathol Res Pract. 2024 Aug;260:155354. doi: 10.1016/j.prp.2024.155354. Epub 2024 May 15.
3
Meta-analysis shows that mesenchymal stem cell therapy can be a possible treatment for diabetes.
用于先天性缺陷重建的颅颌面来源间充质干细胞
Biomolecules. 2025 Jun 30;15(7):953. doi: 10.3390/biom15070953.
4
Induced Pluripotent (iPSC) and Mesenchymal (MSC) Stem Cells for In Vitro Disease Modeling and Regenerative Medicine.用于体外疾病建模和再生医学的诱导多能干细胞(iPSC)和间充质干细胞(MSC)
Int J Mol Sci. 2025 Jun 11;26(12):5617. doi: 10.3390/ijms26125617.
荟萃分析表明,间充质干细胞治疗可能是糖尿病的一种可行治疗方法。
Front Endocrinol (Lausanne). 2024 May 10;15:1380443. doi: 10.3389/fendo.2024.1380443. eCollection 2024.
4
Stem Cell Therapy, the Market, the Opportunities and the Threat.干细胞疗法、市场、机遇与威胁
Int J Mol Cell Med. 2023;12(3):310-319. doi: 10.22088/IJMCM.BUMS.12.3.310.
5
The efficiency of stem cell differentiation into functional beta cells for treating insulin-requiring diabetes: Recent advances and current challenges.干细胞分化为功能性β细胞治疗胰岛素依赖型糖尿病的效率:最新进展和当前挑战。
Endocrine. 2024 Oct;86(1):1-14. doi: 10.1007/s12020-024-03855-8. Epub 2024 May 10.
6
Challenges and Considerations of Preclinical Development for iPSC-Based Myogenic Cell Therapy.基于 iPSC 的肌源性细胞治疗的临床前开发的挑战与考量。
Cells. 2024 Mar 29;13(7):596. doi: 10.3390/cells13070596.
7
Advancements in Human Embryonic Stem Cell Research: Clinical Applications and Ethical Issues.人类胚胎干细胞研究进展:临床应用与伦理问题。
Tissue Eng Regen Med. 2024 Apr;21(3):379-394. doi: 10.1007/s13770-024-00627-3. Epub 2024 Mar 19.
8
The Challenges to Advancing Induced Pluripotent Stem Cell-Dependent Cell Replacement Therapy.推进诱导多能干细胞依赖性细胞替代疗法面临的挑战。
Med Res Arch. 2023 Nov;11(11). doi: 10.18103/mra.v11i11.4784. Epub 2023 Nov 29.
9
CRISPR/Cas9 Landscape: Current State and Future Perspectives.CRISPR/Cas9 全景:现状与未来展望。
Int J Mol Sci. 2023 Nov 8;24(22):16077. doi: 10.3390/ijms242216077.
10
First-in-human transplantation of autologous induced neural stem cell-derived dopaminergic precursors to treat Parkinson's disease.首次将自体诱导神经干细胞来源的多巴胺能前体细胞移植用于治疗帕金森病。
Sci Bull (Beijing). 2023 Nov 30;68(22):2700-2703. doi: 10.1016/j.scib.2023.10.020. Epub 2023 Oct 27.